Literature DB >> 33655765

Standardization of methods for sampling the distal airspace in mechanically ventilated patients using heat moisture exchange filter fluid.

Julie A Bastarache1,2,3, J Brennan McNeil1, Erin J Plosa4, Jennifer S Sucre4, V Eric Kerchberger1, Luke E Habegger1, Elizabeth Weddle1, Briana Sullivan1, Jamie E Meegan1, Nancy E Wickersham1, Ciara M Shaver1, Lorraine B Ware1,2.   

Abstract

Noninvasive sampling of the distal airspace in patients with acute respiratory distress syndrome (ARDS) has long eluded clinical and translational researchers. We recently reported that fluid collected from heat moisture exchange (HME) filters closely mirrors fluid directly aspirated from the distal airspace. In the current study, we sought to determine fluid yield from different HME types, optimal HME circuit dwell time, and reliability of HME fluid in reflecting the distal airspace. We studied fluid yield from four different filter types by loading increasing volumes of saline and measuring volumes of fluid recovered. We collected filters after 1, 2, and 4 h of dwell time for measurement of fluid volume and total protein from 13 subjects. After identifying 4 h as the optimal dwell time, we measured total protein and IgM in HME fluid from 42 subjects with ARDS and nine with hydrostatic pulmonary edema (HYDRO). We found that the fluid yield varies greatly by filter type. With timed sample collection, fluid recovery increased with increasing circuit dwell time with a median volume of 2.0 mL [interquartile range (IQR) 1.2-2.7] after 4 h. Total protein was higher in the 42 subjects with ARDS compared with nine with HYDRO [median 708 µg/mL (IQR 244-2017) vs. 364 µg/mL (IQR 136-578), P = 0.047], confirming that total protein concentration in HME is higher in ARDS compared with hydrostatic edema. These studies establish a standardized HME fluid collection protocol and confirm that HME fluid analysis is a novel noninvasive tool for the study of the distal airspace in ARDS.

Entities:  

Keywords:  ARDS; acute respiratory distress syndrome; biomarkers; exhaled breath; pulmonary edema

Mesh:

Year:  2021        PMID: 33655765      PMCID: PMC8174823          DOI: 10.1152/ajplung.00595.2020

Source DB:  PubMed          Journal:  Am J Physiol Lung Cell Mol Physiol        ISSN: 1040-0605            Impact factor:   6.011


  18 in total

1.  Higher mini-BAL total protein concentration in early ARDS predicts faster resolution of lung injury measured by more ventilator-free days.

Authors:  Carolyn M Hendrickson; Jason Abbott; Hanjing Zhuo; Kathleen D Liu; Carolyn S Calfee; Michael A Matthay
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2017-02-17       Impact factor: 5.464

2.  Fas and fas ligand are up-regulated in pulmonary edema fluid and lung tissue of patients with acute lung injury and the acute respiratory distress syndrome.

Authors:  Kurt H Albertine; Matthew F Soulier; Zhengming Wang; Akitoshi Ishizaka; Satoru Hashimoto; Guy A Zimmerman; Michael A Matthay; Lorraine B Ware
Journal:  Am J Pathol       Date:  2002-11       Impact factor: 4.307

3.  Intact epithelial barrier function is critical for the resolution of alveolar edema in humans.

Authors:  M A Matthay; J P Wiener-Kronish
Journal:  Am Rev Respir Dis       Date:  1990-12

Review 4.  Soluble intercellular adhesion molecule-1 and clinical outcomes in patients with acute lung injury.

Authors:  Carolyn S Calfee; Mark D Eisner; Polly E Parsons; B Taylor Thompson; Edward R Conner; Michael A Matthay; Lorraine B Ware
Journal:  Intensive Care Med       Date:  2008-08-01       Impact factor: 17.440

5.  Exhaled breath condensate isoprostanes are elevated in patients with acute lung injury or ARDS.

Authors:  C T Carpenter; P V Price; B W Christman
Journal:  Chest       Date:  1998-12       Impact factor: 9.410

6.  Pulmonary edema fluid from patients with early lung injury stimulates fibroblast proliferation through IL-1 beta-induced IL-6 expression.

Authors:  Mitchell A Olman; Kimberly E White; Lorraine B Ware; Warren L Simmons; Etty N Benveniste; Sha Zhu; Jerome Pugin; Michael A Matthay
Journal:  J Immunol       Date:  2004-02-15       Impact factor: 5.422

7.  Prognostic value of surfactant proteins A and D in patients with acute lung injury.

Authors:  Ivan W Cheng; Lorraine B Ware; Kelly E Greene; Thomas J Nuckton; Mark D Eisner; Michael A Matthay
Journal:  Crit Care Med       Date:  2003-01       Impact factor: 7.598

8.  The value of edema fluid protein measurement in patients with pulmonary edema.

Authors:  A Fein; R F Grossman; J G Jones; E Overland; L Pitts; J F Murray; N C Staub
Journal:  Am J Med       Date:  1979-07       Impact factor: 4.965

9.  Acute respiratory distress syndrome: the Berlin Definition.

Authors:  V Marco Ranieri; Gordon D Rubenfeld; B Taylor Thompson; Niall D Ferguson; Ellen Caldwell; Eddy Fan; Luigi Camporota; Arthur S Slutsky
Journal:  JAMA       Date:  2012-06-20       Impact factor: 56.272

10.  Endothelial glycocalyx degradation is more severe in patients with non-pulmonary sepsis compared to pulmonary sepsis and associates with risk of ARDS and other organ dysfunction.

Authors:  Laura S Murphy; Nancy Wickersham; J Brennan McNeil; Ciara M Shaver; Addison K May; Julie A Bastarache; Lorraine B Ware
Journal:  Ann Intensive Care       Date:  2017-10-06       Impact factor: 6.925

View more
  2 in total

1.  Sensitivity and specificity of heat and moisture exchange filters sampling for SARS-CoV-2 detection in mechanically ventilated COVID-19 patients.

Authors:  Toufik Kamel; Clémence Guillaume; Grégoire Muller; Lekbir Baala; Thierry Boulain
Journal:  J Microbiol Immunol Infect       Date:  2022-04-14       Impact factor: 10.273

2.  Alveolar epithelial glycocalyx degradation mediates surfactant dysfunction and contributes to acute respiratory distress syndrome.

Authors:  Alicia N Rizzo; Sarah M Haeger; Kaori Oshima; Yimu Yang; Alison M Wallbank; Ying Jin; Marie Lettau; Lynda A McCaig; Nancy E Wickersham; J Brennan McNeil; Igor Zakharevich; Sarah A McMurtry; Christophe J Langouët-Astrié; Katrina W Kopf; Dennis R Voelker; Kirk C Hansen; Ciara M Shaver; V Eric Kerchberger; Ryan A Peterson; Wolfgang M Kuebler; Matthias Ochs; Ruud Aw Veldhuizen; Bradford J Smith; Lorraine B Ware; Julie A Bastarache; Eric P Schmidt
Journal:  JCI Insight       Date:  2022-01-25
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.